Aisling Capital typically makes investments in healthcare companies that require $20-50 million or more in new capital. The size of the investment is contingent upon the company’s stage of development, funding needs and risk profile. Aisling Capital will often participate in further rounds of financing following our initial investment. We have served as the lead or co-lead investor for the majority of our commitments to date.
